SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-23-071872
Filing Date
2023-12-20
Accepted
2023-12-20 16:03:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 424b3_dec2023_resale_pro.htm 424B3 313824
2 GRAPHIC img50591774_0.jpg GRAPHIC 30932
3 GRAPHIC img50591774_1.jpg GRAPHIC 54187
  Complete submission text file 0000950170-23-071872.txt   432408
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-275893 | Film No.: 231501352
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)